| Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, LF Anderson, ... The Lancet 392 (10150), 821-834, 2018 | 515 | 2018 |
| Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study K Dheda, K Shean, A Zumla, M Badri, EM Streicher, L Page-Shipp, ... The Lancet 375 (9728), 1798-1807, 2010 | 317 | 2010 |
| High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers MR O'Donnell, J Jarand, M Loveday, N Padayatchi, J Zelnick, L Werner, ... Annals of internal medicine 153 (8), 516-522, 2010 | 255 | 2010 |
| Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study T Dalton, P Cegielski, S Akksilp, L Asencios, JC Caoili, SN Cho, ... The Lancet 380 (9851), 1406-1417, 2012 | 253 | 2012 |
| Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study A Sharma, A Hill, E Kurbatova, M van der Walt, C Kvasnovsky, TE Tupasi, ... The Lancet Infectious Diseases 17 (7), 707-715, 2017 | 177 | 2017 |
| Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two … EV Kurbatova, JP Cegielski, C Lienhardt, R Akksilp, J Bayona, ... The Lancet Respiratory medicine 3 (3), 201-209, 2015 | 169 | 2015 |
| Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis JP Cegielski, T Dalton, M Yagui, W Wattanaamornkiet, GV Volchenkov, ... Clinical Infectious Diseases 59 (8), 1049-1063, 2014 | 156 | 2014 |
| Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection MR O’Donnell, N Padayatchi, C Kvasnovsky, L Werner, I Master, ... Emerging infectious diseases 19 (3), 416, 2013 | 141 | 2013 |
| Multidrug-resistant tuberculosis treatment outcomes in relation to treatment and initial versus acquired second-line drug resistance JP Cegielski, E Kurbatova, M Van Der Walt, J Brand, J Ershova, T Tupasi, ... Clinical Infectious Diseases 62 (4), 418-430, 2016 | 115 | 2016 |
| BMI as a risk factor for clinical outcomes in patients hospitalized with COVID‐19 in New York TS Kim, M Roslin, JJ Wang, J Kane, JS Hirsch, EJ Kim, ... Obesity 29 (2), 279-284, 2021 | 111 | 2021 |
| Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease CL Kvasnovsky, U Aujla, I Bjarnason Scandinavian journal of gastroenterology 50 (3), 255-263, 2015 | 99 | 2015 |
| Usefulness of elevated troponin to predict death in patients with COVID-19 and myocardial injury DT Majure, L Gruberg, SG Saba, C Kvasnovsky, JS Hirsch, R Jauhar, ... The American journal of cardiology 138, 100-106, 2021 | 93 | 2021 |
| Increased diverticular complications with nonsteriodal anti‐inflammatory drugs and other medications: a systematic review and meta‐analysis CL Kvasnovsky, S Papagrigoriadis, I Bjarnason Colorectal Disease 16 (6), O189-O196, 2014 | 87 | 2014 |
| Limiting hospital resources for acute appendicitis in children: Lessons learned from the US epicenter of the COVID-19 pandemic CL Kvasnovsky, Y Shi, BS Rich, RD Glick, SZ Soffer, AM Lipskar, S Dolgin, ... Journal of pediatric surgery 56 (5), 900-904, 2021 | 75 | 2021 |
| Extensively drug-resistant TB in Eastern Cape, South Africa: high mortality in HIV-negative and HIV-positive patients CL Kvasnovsky, JP Cegielski, R Erasmus, NO Siwisa, K Thomas, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 57 (2), 146-152, 2011 | 73 | 2011 |
| Extensively drug‐resistant tuberculosis (XDR‐TB) among health care workers in South Africa J Jarand, K Shean, M O’Donnell, M Loveday, C Kvasnovsky, ... Tropical Medicine & International Health 15 (10), 1179-1184, 2010 | 61 | 2010 |
| Characteristics and risk factors associated with critical illness in pediatric COVID-19 G Fisler, SM Izard, S Shah, D Lewis, MK Kainth, SHF Hagmann, JA Belfer, ... Annals of Intensive Care 10, 1-8, 2020 | 56 | 2020 |
| Clinical and symptom scores are significantly correlated with fecal microbiota features in patients with symptomatic uncomplicated diverticular disease: a pilot study CL Kvasnovsky, LEX Leong, JM Choo, GCJ Abell, S Papagrigoriadis, ... European journal of gastroenterology & hepatology 30 (1), 107-112, 2018 | 55 | 2018 |
| Association between regimen composition and treatment response in patients with multidrug-resistant tuberculosis: a prospective cohort study CM Yuen, EV Kurbatova, T Tupasi, JC Caoili, M Van Der Walt, ... PLoS medicine 12 (12), e1001932, 2015 | 54 | 2015 |
| An early experience on the effect of solid organ transplant status on hospitalized COVID‐19 patients V Nair, N Jandovitz, JS Hirsch, M Abate, SK Satapathy, N Roth, SJ Miyara, ... American Journal of Transplantation 21 (7), 2522-2531, 2021 | 51 | 2021 |
